Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1323788
                    [Title] => Study: Antidepressant may cut Alzheimer's protein
                    [Summary] => 
Research shows a common antidepressant may cut production of one of the chief suspects behind Alzheimer's, a new avenue in the hunt for drugs to prevent the devastating brain disease.

                    [DatePublished] => 2014-05-16 07:07:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 920686
                    [Title] => Despite setbacks, Alzheimer’s tx pipeline is full
                    [Summary] => 
More than 60 drugs remain in the developmental pipeline for Alzheimer’s disease, although the past several years have seen numerous once-promising agents bite the dust.

                    [DatePublished] => 2013-03-17 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 891424
                    [Title] => New imaging agent correlates amyloid with Alzheimer’s
                    [Summary] => 
Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom had some form of dementia.

                    [DatePublished] => 2012-12-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 610883
                    [Title] => Amyloid theory sputters for AD
                    [Summary] => 
The amyloid hypothesis isn’t dead, but it seems to be limping a bit in the race for an Alzheimer’s cure.
                    [DatePublished] => 2010-09-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 498130
                    [Title] => Amyloid scans may aid Alzheimer's diagnosis
                    [Summary] => 
Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a Food and Drug administration advisory panel.
                    [DatePublished] => 2009-08-23 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

AMYLOID

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1323788
                    [Title] => Study: Antidepressant may cut Alzheimer's protein
                    [Summary] => 
Research shows a common antidepressant may cut production of one of the chief suspects behind Alzheimer's, a new avenue in the hunt for drugs to prevent the devastating brain disease.

                    [DatePublished] => 2014-05-16 07:07:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 920686
                    [Title] => Despite setbacks, Alzheimer’s tx pipeline is full
                    [Summary] => 
More than 60 drugs remain in the developmental pipeline for Alzheimer’s disease, although the past several years have seen numerous once-promising agents bite the dust.

                    [DatePublished] => 2013-03-17 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 891424
                    [Title] => New imaging agent correlates amyloid with Alzheimer’s
                    [Summary] => 
Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom had some form of dementia.

                    [DatePublished] => 2012-12-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 610883
                    [Title] => Amyloid theory sputters for AD
                    [Summary] => 
The amyloid hypothesis isn’t dead, but it seems to be limping a bit in the race for an Alzheimer’s cure.
                    [DatePublished] => 2010-09-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 498130
                    [Title] => Amyloid scans may aid Alzheimer's diagnosis
                    [Summary] => 
Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a Food and Drug administration advisory panel.
                    [DatePublished] => 2009-08-23 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Study: Antidepressant may cut Alzheimer's protein

May 16, 2014 - 7:07am

Research shows a common antidepressant may cut production of one of the chief suspects behind Alzheimer's, a new avenue in the hunt for drugs to prevent the devastating brain disease.

Health And Family

Despite setbacks, Alzheimer’s tx pipeline is full

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | March 17, 2013 - 12:00am

More than 60 drugs remain in the developmental pipeline for Alzheimer’s disease, although the past several years have seen numerous once-promising agents bite the dust.

Opinion

New imaging agent correlates amyloid with Alzheimer’s

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 30, 2012 - 12:00am

Positron-emission tomography in combination with the radio labeled compound florbetapir F-18 detected beta-amyloid plaques with 93% sensitivity and 100% specificity in the brains of 35 elderly patients, most of whom...

Opinion

Amyloid theory sputters for AD

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 12, 2010 - 12:00am

The amyloid hypothesis isn’t dead, but it seems to be limping a bit in the race for an Alzheimer’s cure.

Opinion

Amyloid scans may aid Alzheimer's diagnosis

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | August 23, 2009 - 12:00am

Radionuclide imaging products that reliably detect cerebral amyloid deposits would be clinically useful in ruling out a diagnosis of Alzheimer’s disease in patients with cognitive impairment, according to a...

Opinion